Benjamin Robey
University of North Carolina at Chapel Hill
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Benjamin Robey.
Clinical and translational gastroenterology | 2017
Swathi Eluri; Thomas Runge; Jason M. Hansen; Bharati Kochar; Craig C. Reed; Benjamin Robey; John T. Woosley; Nicholas J. Shaheen; Evan S. Dellon
OBJECTIVES: While topical corticosteroids are first‐line therapy for eosinophilic esophagitis (EoE), the data regarding long‐term effectiveness are lacking. We aimed to determine long‐term histologic and endoscopic outcomes of maintenance therapy in EoE steroid responders. METHODS: We performed a retrospective study of adults with EoE at UNC Hospitals who had initial histologic response (<15 eos/hpf) after 8 weeks of topical steroids, and maintained on therapy. Endoscopic and the histologic data were recorded at baseline and follow‐up endoscopies. Multivariable logistic regression was performed to assess loss of treatment response by steroid dose at recurrence, and Kaplan–Meier analysis to calculate durability of disease remission. RESULTS: Of 55 EoE patients with initial response to swallowed/topical fluticasone or budesonide over a median 11.7 months, 33 had at least two follow‐up EGDs. Of these patients, 61% had histologic loss of response and worse endoscopic findings. There was no difference in baseline steroid dose (P=0.55) between the groups, but those maintained on their initial dose had lower odds (OR: 0.10; 95% CI: 0.01, 0.90) of loss of response compared to those who had subsequent dose reduction. On survival analysis, 50% had loss of response to steroids by 18.5 months and 75% by 29.6 months. CONCLUSIONS: In adult EoE steroid responders, loss of treatment response is common, and is associated with a steroid dose reduction. Routinely lowering doses for maintenance steroids may provide inferior outcomes.
Clinical Gastroenterology and Hepatology | 2018
Craig C. Reed; Nathaniel T. Koutlas; Benjamin Robey; Jason M. Hansen; Evan S. Dellon
&NA; Eosinophilic esophagitis (EoE) is a chronic condition characterized by eosinophilic‐predominant inflammation and esophageal dysfunction.1,2 EoE represents a rapidly increasing cause of morbidity and a growing health problem.
ACG Case Reports Journal | 2018
Benjamin Robey; Anne F. Peery; Evan S. Dellon
Marfan syndrome is an autosomal dominant disorder involving mutation in the FBN1 gene, which encodes fibrillin-1, a protein critical to maintain the integrity of connective tissue. A mutation in this gene can affect multiple organ systems, but it is not classically associated with gastrointestinal complications. We describe a man with Marfan syndrome with multiple small bowel diverticula leading to small intestinal bacterial overgrowth and recurrent small bowel perforations.
Dysphagia | 2016
W. Asher Wolf; Kevin Z. Huang; Raquel Durban; Zahra Iqbal; Benjamin Robey; Farah J. Khalid; Evan S. Dellon
The Journal of Allergy and Clinical Immunology | 2018
Scott P. Commins; Benjamin Robey; Barrett H. Barnes; Craig C. Reed; Swathi Eluri; Michelle L. Hernandez; Maya R. Jerath; Evan S. Dellon
Gastroenterology | 2018
Swathi Eluri; Manaswita Tappata; Kevin Z. Huang; Nathaniel T. Koutlas; Benjamin Robey; Claire Fan; Craig C. Reed; Nicholas J. Shaheen; Evan S. Dellon
Gastroenterology | 2018
Kelli DeLay; Manaswita Tappata; Kevin Z. Huang; Nathaniel T. Koutlas; Benjamin Robey; Claire Fan; Swathi Eluri; Paul Menard-Katcher; Evan S. Dellon
Gastroenterology | 2017
Benjamin Robey; Swathi Eluri; Craig C. Reed; Maya R. Jerath; Michelle L. Hernandez; Scott P. Commins; Evan S. Dellon
Gastroenterology | 2017
Craig C. Reed; Nathaniel T. Koutlas; Benjamin Robey; Jason M. Hansen; Swathi Eluri; Evan S. Dellon
Gastroenterology | 2016
Swathi Eluri; Thomas Runge; Jason M. Hansen; Bharati Kochar; Craig C. Reed; Benjamin Robey; John T. Woosley; Nicholas J. Shaheen; Evan S. Dellon